Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
CBSN
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose - a fifth of the dose of its current COVID-19 vaccine, Spikevax - by refining its immune target.
The approval "adds an important new tool to help protect people at high risk of severe disease from COVID-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday.

The race to fill the seat of retiring Illinois Sen. Dick Durbin has been heating up in the days leading up to Tuesday's 2026 Democratic primary and could set the tone for other midterm primaries on issues like President Trump's deportation policies and outside spending. And another factor in the race is Gov. JB Pritzker's attempt at powerbrokering: he's given his endorsement and millions in campaign funds to his lieutenant governor, Julianna Stratton. In:

A man who was accused of planting pipe bombs outside the Republican National Committee and Democratic National Committee headquarters on the eve of the Jan. 6 attack in 2021 is asking a judge to dismiss the criminal charges against him, arguing he is covered by President Trump's sweeping pardons of alleged Jan. 6 rioters.

The Cuban government is planning to allow Cuban nationals who live abroad — including in the U.S. — to invest in companies on the island, a top government official told NBC News in an interview that aired Monday, as the country faces economic collapse and immense pressure from the Trump administration.










